Evidence map›Paper›PMID 40429070›Full record

ArticleMaterials (Basel, Switzerland)2025

Zirconium Phosphonate Sorbent Materials-Synthesis, Characterization, and Application for Copper Removal from Acidic Wastewater.

Marta Marszałek, Marcin Piotrowski, Bożena Druzgała, Zbigniew Wzorek

Abstract read
In one paragraph

Article in Materials (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Marta MarszałekCracow University of Technology, Faculty of Chemical Engineering and Technology, Warszawska 24, 31-155 Krakow, Poland.
Marcin PiotrowskiCracow University of Technology, Faculty of Chemical Engineering and Technology, Warszawska 24, 31-155 Krakow, Poland.
Bożena DruzgałaCracow University of Technology, Faculty of Chemical Engineering and Technology, Warszawska 24, 31-155 Krakow, Poland.
Zbigniew WzorekCracow University of Technology, Faculty of Chemical Engineering and Technology, Warszawska 24, 31-155 Krakow, Poland.ORCID 0000-0001-9077-4699

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Copper removal from wastewater is a major challenge in the treatment of both hydrometallurgical copper recycling effluents and mining wastewater. The use of sorbents is considered the most efficient and environmentally friendly method for this purpose. Zirconium aminotris(methylenephosphonates) exhibit excellent sorption properties towards many metal ions. Therefore, the goal of this research was to synthesize amorphous zirconium phosphonate materials with a wide range of P:Zr molar ratios (0.5-100) in the reaction mixture and under mild conditions. The obtained sorbents were characterized using ATR-FTIR, XRD, SEM-EDS, CHN analysis, and pH titration. The sorption properties of the zirconium aminotris(methylenephosphonates) were studied in pure copper solutions and in the complex acidic solutions (pH 1.6-3.2). The results were compared with those for the commercially available resins designed to capture copper containing iminodiacetic acid and bispicolylamine as surface groups. Zirconium aminotris(methylenephosphonate) synthesized at a P:Zr molar ratio of 50:1 shows fast sorption kinetics and the best sorption properties. The maximum sorption capacity in pure copper solutions is 62.3 mg/g, and its affinity for copper ions is comparable to that of reference resins

Indexed as

acidic wastewateraminotris(methylenephosphonic acid)chelating resincopper sorptionzirconium phosphonate

Identifiers

PMID40429070
PMCPMC12113369

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.